We are live on ! Find out more
AAM

Aston Asset Management Portfolio holdings

AUM $164M
1-Year Est. Return 2.95%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+2.95%
3 Year Est. Return
+26.08%
5 Year Est. Return
10 Year Est. Return
AUM
$407M
AUM Growth
+$39M
Cap. Flow
+$9.89M
Cap. Flow %
2.43%
Top 10 Hldgs %
18.7%
Holding
154
New
15
Increased
80
Reduced
43
Closed
15

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$4.97M
2
PFE icon
Pfizer
PFE
+$3.79M
3
MDT icon
Medtronic
MDT
+$3.56M
4
PAYX icon
Paychex
PAYX
+$2.99M
5
MOLX
MOLEX INC
MOLX
+$2.58M

Sector Composition

Rank Sector Weight
1 Industrials 17.49%
2 Technology 14.69%
3 Consumer Staples 13.29%
4 Consumer Discretionary 11.41%
5 Financials 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYT icon
51
New York Times
NYT
$12.4B
$3.15M 0.77%
198,293
-24,943
-11% -$339K
WBA
52
DELISTED
Walgreens Boots Alliance
WBA
$3.14M 0.77%
54,735
-85,509
-61% -$4.97M
HSP
53
DELISTED
HOSPIRA INC
HSP
$2.98M 0.73%
72,065
-6,410
-8% -$258K
AKAM icon
54
Akamai
AKAM
$15.8B
$2.88M 0.71%
61,145
+13,631
+29% +$643K
XYL icon
55
Xylem
XYL
$28.6B
$2.85M 0.7%
82,343
-5,143
-6% -$165K
AYR
56
DELISTED
Aircastle Ltd
AYR
$2.8M 0.69%
146,262
+24,671
+20% +$457K
CVSA
57
Covista Inc
CVSA
$4.5B
$2.79M 0.69%
78,561
-13,610
-15% -$470K
FTI icon
58
TechnipFMC
FTI
$28.7B
$2.72M 0.67%
70,000
+25,460
+57% +$988K
CTXS
59
DELISTED
Citrix Systems Inc
CTXS
$2.58M 0.63%
51,135
+33,035
+183% +$1.57M
EW icon
60
Edwards Lifesciences
EW
$49.2B
$2.57M 0.63%
+234,468
New +$2.64M
MDR
61
DELISTED
McDermott International
MDR
$2.51M 0.62%
91,413
-402
-0.4% -$9.41K
AVA icon
62
Avista
AVA
$3.45B
$2.46M 0.61%
87,395
+3,860
+5% +$106K
IPG
63
DELISTED
Interpublic Group of Companies
IPG
$2.45M 0.6%
138,412
+1,205
+0.9% +$20.3K
VAR
64
DELISTED
Varian Medical Systems, Inc.
VAR
$2.44M 0.6%
35,892
+3,668
+11% +$244K
NUAN
65
DELISTED
Nuance Communications, Inc.
NUAN
$2.35M 0.58%
178,747
+23,043
+15% +$317K
AGCO icon
66
AGCO
AGCO
$8.43B
$2.31M 0.57%
38,981
+15,487
+66% +$923K
ITRI icon
67
Itron
ITRI
$4.53B
$2.28M 0.56%
55,111
-2,040
-4% -$86.6K
NVDA icon
68
NVIDIA
NVDA
$4.64T
$2.24M 0.55%
5,600,600
-57,880
-1% -$22.4K
UIS icon
69
Unisys
UIS
$252M
$2.23M 0.55%
66,581
-5,709
-8% -$158K
AA icon
70
Alcoa
AA
$11.3B
$2.21M 0.54%
+86,304
New +$1.91M
JBL icon
71
Jabil
JBL
$30.2B
$2.09M 0.51%
119,939
+19,284
+19% +$391K
BSX icon
72
Boston Scientific
BSX
$68.8B
$2.05M 0.5%
170,273
-91,481
-35% -$1.08M
MEMP
73
DELISTED
Memorial Production Partners LP Common Units
MEMP
$1.98M 0.49%
90,024
+72,823
+423% +$1.5M
PPO
74
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$1.96M 0.48%
+50,397
New +$1.99M
WOLF icon
75
Wolfspeed
WOLF
$1.06B
$1.93M 0.48%
30,931
+3,901
+14% +$241K

Similar funds

Aston Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Aston Asset Management held 154 positions worth $407M, up 11% from $368M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aston Asset Management's Q4 2013 filing shows 15 new, 80 increased, 43 reduced and 15 closed positions. Its largest new stake was Ensco Rowan plc: 18,819 shares worth $4.3M. The largest sale was Walgreens Boots Alliance, an estimated $4.97M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Staples.

  • Aston Asset Management's largest Q4 2013 buy was Ensco Rowan plc: 18,819 shares worth $4.3M.
  • Aston Asset Management added most to Qualcomm in Q4 2013, an estimated $2.96M increase.
  • Aston Asset Management's biggest Q4 2013 reduction was Walgreens Boots Alliance, cutting an estimated $4.97M.
  • Aston Asset Management fully exited Pfizer in Q4 2013, selling an estimated $3.79M.
  • Aston Asset Management's ten largest holdings make up 19% of its $407M portfolio in Q4 2013.
  • Aston Asset Management opened 15 new positions and closed 15 in Q4 2013.
  • Aston Asset Management's portfolio value rose 11% quarter-over-quarter to $407M.

Based on Aston Asset Management's 13F filing for Q4 2013, filed 14 Feb 2014.